Please login to the form below

companion diagnostic

This page shows the latest companion diagnostic news and features for those working in and with pharma, biotech and healthcare.

Loxo, Bayer get FDA okay for biomarker-driven cancer drug

At the moment there is no companion diagnostic for NTRK fusions so patients need to be identified through genomic profiling techniques such as immunohistochemistry or genetic sequencing approaches, which tend to ... To try to address the diagnostic issue,

Latest news

Loxo, Bayer get quick FDA review for ‘precision’ cancer drug

To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether
EMA starts firming up its stance on personalised medicines

The European Medicines Agency (EMA) hopes that when finalised they will help optimise the co-development of medicines and companion diagnostics. ... As diagnostic medical devices, companion diagnostics do not fall within the oversight of the EMA, but the
Celgene, Agios get FDA OK for leukaemia drug Idhifa

A companion diagnostic from Abbott Labs that detects mutations in the IDH2 gene in blood or bone marrow samples has been approved alongside the new drug.
AZ takes Chi-Med’s kidney cancer drug into phase III

He noted that the company has developed a companion diagnostic that will be used to select patients for its phase III programme.
AZ gets first OK for PD-L1 inhibitor durvalumab

The FDA also approved Roche's Ventana PD-L1 assay as a companion diagnostic for assessing PD-L1 protein levels in biopsy tissue.

More from news
Approximately 1 fully matching, plus 53 partially matching documents found.

Latest Intelligence

Harnessing complexity

This delicate balance between companion diagnostics' clinical utility and their potential confounding impact on patient treatment is a growing dilemma. ... Answering this question in full requires a scientific journey to better understand what a
Diagnostics are rising up the pharma value chain

Diagnostic drivers. It's not just this idea of changing public attitudes that is creating renewed interest in the diagnostics sector; the sector is also influenced by the wider forces affecting ... GlaxoSmithKline and Boehringer Ingelheim have had
Deal Watch table for June 2014

50. NanoString Technologies/ Celgene. Development. Development of a companion diagnostic assay.
Pharma deals during June 2014

a deal with NanoString Technologies for the development of a companion diagnostic assay to support the development of Revlimid for treatment of Diffuse Large B-Cell Lymphoma at a more modest
Interview: John Dineen, GE Healthcare

some of these markers can be converted into a companion diagnostic product after the completion of a late-stage clinical trial. ... We can then ensure our diagnostic is closely coupled with the therapeutic capability.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

Mastering the precision medicine opportunity

Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... approval of their new FoundationOne CDx, the first and

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director – Healthcare Marketing – Berks: Salary TBC

Medical Writer: Salary TBC

Senior Account Manager: Competitive Salary Offered

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Medical Writer: Salary TBC

Account Director: Competitive Salary Offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Global Business Development Director – Health Education: excellent commission

Account Director, Medical Education: Salary TBC

Account Manager / Account Director: Competative

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Account Director development role to Business Director, H...: Excellent package

Associate Director: £75, 000-90, 000

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Senior Director – Healthcare PR – Global Agency: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Business Director: Competitive Salary Offered

Subscribe to our email news alerts

PMHub

Add my company

OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....